Smoking Addiction Global Clinical Trials Review, Q2, 2011
GlobalData
June 21, 2011 69 Pages - SKU: GBDT6421620
|
|
Smoking Addiction Global Clinical Trials Review, Q2, 2011
Summary
GlobalData's clinical trial report, “Smoking Addiction Global Clinical Trials Review, Q2, 2011 provides data on the Smoking Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Smoking Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Smoking Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- Introduction
- Smoking Addiction
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Smoking Addiction
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Smoking Addiction Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- Sanofi-Aventis
- Clinical Trial Overview of Sanofi-Aventis
- Johnson & Johnson
- Clinical Trial Overview of Johnson & Johnson
- Nabi Biopharmaceuticals
- Clinical Trial Overview of Nabi Biopharmaceuticals
- Star Scientific, Inc.
- Clinical Trial Overview of Star Scientific, Inc.
- GlaxoSmithKline plc
- Clinical Trial Overview of GlaxoSmithKline plc
- Swiss Tobacco Prevention Fund
- Clinical Trial Overview of Swiss Tobacco Prevention Fund
- CigArrest Pty Ltd
- Clinical Trial Overview of CigArrest Pty Ltd
- Rock Creek Pharmaceuticals INC
- Clinical Trial Overview of Rock Creek Pharmaceuticals INC
- Celtic Pharmaceutical Holdings L.P.
- Clinical Trial Overview of Celtic Pharmaceutical Holdings L.P.
- Evotec Neurosciences GmbH
- Clinical Trial Overview of Evotec Neurosciences GmbH
- Cytos Biotechnology AG
- Clinical Trial Overview of Cytos Biotechnology AG
- Somaxon Pharmaceuticals, Inc.
- Clinical Trial Overview of Somaxon Pharmaceuticals, Inc.
- Elan Corporation, plc
- Clinical Trial Overview of Elan Corporation, plc
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Mayo Clinic
- Clinical Trial Overview of Mayo Clinic
- The University of Texas M. D. Anderson Cancer Center
- Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
- U.S. Department of Veterans Affairs
- Clinical Trial Overview of U.S. Department of Veterans Affairs
- University of California, San Francisco
- Clinical Trial Overview of University of California, San Francisco
- Massachusetts General Hospital
- Clinical Trial Overview of Massachusetts General Hospital
- University of Pennsylvania
- Clinical Trial Overview of University of Pennsylvania
- Duke University
- Clinical Trial Overview of Duke University
- Centre for Addiction and Mental Health
- Clinical Trial Overview of Centre for Addiction and Mental Health
- Yale University
- Clinical Trial Overview of Yale University
- University of Medicine and Dentistry New Jersey
- Clinical Trial Overview of University of Medicine and Dentistry New Jersey
- University of Pittsburgh
- Clinical Trial Overview of University of Pittsburgh
- Virginia Commonwealth University
- Clinical Trial Overview of Virginia Commonwealth University
- Queen Mary, University of London
- Clinical Trial Overview of Queen Mary, University of London
- University Health Network
- Clinical Trial Overview of University Health Network
- New York State Psychiatric Institute
- Clinical Trial Overview of New York State Psychiatric Institute
- University of Connecticut Health Center
- Clinical Trial Overview of University of Connecticut Health Center
- The University of Maryland
- Clinical Trial Overview of The University of Maryland
- Jordi Gol i Gurina Foundation
- Clinical Trial Overview of Jordi Gol i Gurina Foundation
- University of Wisconsin Madison
- Clinical Trial Overview of University of Wisconsin Madison
- University of Rochester
- Clinical Trial Overview of University of Rochester
- Group Health Cooperative
- Clinical Trial Overview of Group Health Cooperative
- Kaiser Permanente
- Clinical Trial Overview of Kaiser Permanente
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Zone, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, North America, Top Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, BRIC Countries, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Phase, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Smoking Addiction Therapeutics Market, Global, Terminated Clinical Trials, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Smoking Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabi Biopharmaceuticals, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Star Scientific, Inc., 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Tobacco Prevention Fund, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by CigArrest Pty Ltd, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Celtic Pharmaceutical Holdings L.P., 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Evotec Neurosciences GmbH, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytos Biotechnology AG, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Somaxon Pharmaceuticals, Inc., 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Elan Corporation, plc, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary, University of London, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Maryland, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Jordi Gol i Gurina Foundation, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Group Health Cooperative, 2011*
- Smoking Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaiser Permanente, 2011*
- List of Figures
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
- Smoking Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
- Smoking Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
- Smoking Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011*
- Smoking Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011*
- Smoking Addiction Therapeutics Clinical Trials, BRIC Countries (%), 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
- Smoking Addiction Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Smoking Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Smoking Addiction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- GlobalData Methodology
Share this report
Other tasks Related Markets Smoking Cessation Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
